| IPI00026108 - PLA2G4A, CYTOSOLIC PHOSPHOLIPASE A2. | |
|---|---|
| Uniprot Accession: Q5TFJ2 | |
| Uniprot ID: Q5TFJ2_HUMAN | |
| Mapping: Chr 1, 185064708 - 185224736 | |
| Entrez Gene: 5321 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_11355) |
|---|
| Rat: Pla2g4a, CYTOSOLIC PHOSPHOLIPASE A2. |
| Mouse: Pla2g4a, CYTOSOLIC PHOSPHOLIPASE A2. |
| Mouse: Pla2g4a, CALCIUM-DEPENDENT), FULL INSERT SEQUENCE. |
| Rat: Pla2g4a, CYTOSOLIC PHOSPHOLIPASE A2, GROUP IVA. |
| Human: PLA2G4A, CYTOSOLIC PHOSPHOLIPASE A2. |
| Human: PLA2G4A, CYTOSOLIC PHOSPHOLIPASE A2 (FRAGMENT). |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| cytosol | C | NAS | ISS | |
| integral to membrane | C | NAS | ISS | |
| cytoplasmic vesicle | C | IEA | IEA | |
| cytoplasm | C | IEA | IEA | |
| hydrolase activity | F | IEA | IEA | IEA |
| calcium ion binding | F | IEA | IEA | IEA |
| phospholipase activity | F | IEA | ||
| phospholipase A2 activity | F | NAS | IEA | TAS ISS IEA |
| subtilase activity | F | RCA | ISS | |
| lysophospholipase activity | F | IEA | IEA | IEA |
| lipid catabolic process | P | IEA | IEA | IEA |
| icosanoid metabolic process | P | NAS | ISS | |
| platelet activating factor biosynthetic process | P | NAS | ISS | |
| proteolysis | P | RCA | ISS | |
| phospholipid catabolic process | P | IEA | IEA | IEA |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| endocrine/exocrine gland phenotype | MP | Un | ||
| homeostasis/metabolism phenotype | MP | Un | ||
| immune system phenotype | MP | Un | ||
| renal/urinary system phenotype | MP | Un | ||
| respiratory system phenotype | MP | Un | ||
| digestive/alimentary phenotype | MP | Un | ||
| reproductive system phenotype | MP | Un | ||
| growth/size phenotype | MP | Un |
| DO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Hyperalgesia | D | IPM | ||
| Inflammation | D | IPM | ||
| Sepsis | D | IED | ||
| Polycystic Kidney Diseases | D | IEP | ||
| Papilloma | D | IEP | ||
| Asthma | D | IEP | ||
| Fever | D | IEP | ||
| Brain Ischemia | D | IEP | ||
| Liver Cirrhosis, Experimental | D | IEP | ||
| Burns | D | IEP | ||
| Wallerian Degeneration | D | IEP | ||
| Reperfusion Injury | D | IED | ||
| Carcinoma, Transitional Cell | D | IEP | ||
| Hyperglycemia | D | IED |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| GnRH signaling pathway (04912) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Long-term depression (04730) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Glycerophospholipid metabolism (00564) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Ether lipid metabolism (00565) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Fc epsilon RI signaling pathway (04664) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| MAPK signaling pathway (04010) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| VEGF signaling pathway (04370) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Arachidonic acid metabolism (00590) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Linoleic acid metabolism (00591) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |